BioAdaptives, Inc. Files 8-K
Ticker: BDPT · Form: 8-K · Filed: Oct 30, 2024 · CIK: 1575142
| Field | Detail |
|---|---|
| Company | Bioadaptives, INC. (BDPT) |
| Form Type | 8-K |
| Filed Date | Oct 30, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, filing, corporate-event
TL;DR
BioAdaptives filed an 8-K on Oct 30th for an Oct 28th event - check for updates.
AI Summary
BioAdaptives, Inc. filed an 8-K on October 30, 2024, reporting an event on October 28, 2024. The filing indicates a Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits. The company, formerly known as APEX 8 Inc., is incorporated in Delaware and headquartered in Las Vegas, Nevada.
Why It Matters
This 8-K filing signals that BioAdaptives, Inc. has made significant disclosures to the SEC, potentially impacting investor understanding of the company's current status and future outlook.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for disclosures and does not immediately indicate significant negative events.
Key Players & Entities
- BIOADAPTIVES, INC. (company) — Registrant
- APEX 8 Inc. (company) — Former Company Name
- 2024-10-28 (date) — Earliest event reported
- 2024-10-30 (date) — Filing Date
- Las Vegas, Nevada (location) — Principal Executive Office
FAQ
What specific event occurred on October 28, 2024, that prompted this 8-K filing?
The filing indicates 'Regulation FD Disclosure', 'Other Events', and 'Financial Statements and Exhibits' as reasons for the report, but the specific event is not detailed in the provided text.
What was BioAdaptives, Inc. formerly known as?
BioAdaptives, Inc. was formerly known as APEX 8 Inc.
When did the company change its name from APEX 8 Inc.?
The date of the name change from APEX 8 Inc. was April 24, 2013.
Where are BioAdaptives, Inc.'s principal executive offices located?
The principal executive offices of BioAdaptives, Inc. are located at 2620 Regatta Drive, Suite 102, Las Vegas, Nevada 89128.
What is the SIC code for BioAdaptives, Inc.?
The Standard Industrial Classification (SIC) code for BioAdaptives, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 453 words · 2 min read · ~2 pages · Grade level 10.7 · Accepted 2024-10-29 20:23:16
Filing Documents
- bdpt_8k.htm (8-K) — 22KB
- bdpt_ex991.htm (EX-99.1) — 15KB
- bdpt_8kimg1.jpg (GRAPHIC) — 4KB
- 0001640334-24-001612.txt ( ) — 164KB
- bdpt-20241028.xsd (EX-101.SCH) — 6KB
- bdpt-20241028_lab.xml (EX-101.LAB) — 13KB
- bdpt-20241028_cal.xml (EX-101.CAL) — 1KB
- bdpt-20241028_pre.xml (EX-101.PRE) — 8KB
- bdpt-20241028_def.xml (EX-101.DEF) — 2KB
- bdpt_8k_htm.xml (XML) — 3KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure The Company issued a press release on October 29, 2024, reporting the impending reverse split. A copy of this press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information presented in Item 7.01 of this Current Report on Form 8-K and Exhibit 99.1 is being furnished and shall not be deemed filed for the purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise be subject to the liabilities of that section, nor is it incorporated by reference into any filing of the Company, under the Securities Act of 1933, or the Securities Exchange Act of 1934, whether made before or after the date hereof, regardless of any general incorporation language in such filing.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit Number Exhibit Description 99.1 Press Release 2 SIGNATURE Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. October 29, 2024 BioAdaptives, Inc. /s/ James Keener James Keener Director and CEO 3